Mengwen Wang

640 total citations
31 papers, 424 citations indexed

About

Mengwen Wang is a scholar working on Molecular Biology, Neurology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Mengwen Wang has authored 31 papers receiving a total of 424 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 6 papers in Neurology and 5 papers in Cellular and Molecular Neuroscience. Recurrent topics in Mengwen Wang's work include Neurological diseases and metabolism (6 papers), Hereditary Neurological Disorders (5 papers) and Genomics, phytochemicals, and oxidative stress (3 papers). Mengwen Wang is often cited by papers focused on Neurological diseases and metabolism (6 papers), Hereditary Neurological Disorders (5 papers) and Genomics, phytochemicals, and oxidative stress (3 papers). Mengwen Wang collaborates with scholars based in China, Germany and Canada. Mengwen Wang's co-authors include Xingwei He, Jinsheng Lai, Yunjian Liu, Shusheng Li, Chang Xu, Hesong Zeng, Fei Xia, Xiaodan Zhong, Lei Dai and Hesong Zeng and has published in prestigious journals such as Journal of Biological Chemistry, ACS Nano and Brain.

In The Last Decade

Mengwen Wang

29 papers receiving 421 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mengwen Wang China 12 117 102 85 53 44 31 424
Linlin Chen China 14 239 2.0× 70 0.7× 54 0.6× 99 1.9× 13 0.3× 33 592
Rong Zhuang China 11 202 1.7× 16 0.2× 18 0.2× 15 0.3× 22 0.5× 27 457
Rui Lin China 17 324 2.8× 15 0.1× 17 0.2× 22 0.4× 22 0.5× 45 762
Prem Kumar Govindappa United States 13 112 1.0× 11 0.1× 16 0.2× 21 0.4× 15 0.3× 34 479
Meng Wei China 13 188 1.6× 10 0.1× 19 0.2× 49 0.9× 92 2.1× 32 521
Salam Massadeh Saudi Arabia 12 183 1.6× 24 0.2× 17 0.2× 7 0.1× 14 0.3× 27 429
Romain Brusini France 7 141 1.2× 39 0.4× 30 0.4× 6 0.1× 3 0.1× 8 415
Sun-Hyun Park South Korea 9 147 1.3× 7 0.1× 48 0.6× 14 0.3× 33 0.8× 16 481
Patrick Mullen United States 8 171 1.5× 20 0.2× 9 0.1× 7 0.1× 55 1.3× 8 553
Masoud Yousefi Iran 10 265 2.3× 35 0.3× 233 2.7× 8 0.2× 3 0.1× 43 626

Countries citing papers authored by Mengwen Wang

Since Specialization
Citations

This map shows the geographic impact of Mengwen Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mengwen Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mengwen Wang more than expected).

Fields of papers citing papers by Mengwen Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mengwen Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mengwen Wang. The network helps show where Mengwen Wang may publish in the future.

Co-authorship network of co-authors of Mengwen Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Mengwen Wang. A scholar is included among the top collaborators of Mengwen Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mengwen Wang. Mengwen Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Yueqi, Lei Dai, Mengwen Wang, et al.. (2025). Activated Protein C Suppresses Cardiomyocyte Senescence in Diabetic Cardiomyopathy via PAR1/PAR3-P85-CaMKIIδ Axis. Diabetes. 74(10). 1802–1813.
3.
Wang, Mengwen, et al.. (2024). The Osmolality and Hemolysis of High-Concentration Monoclonal Antibody Formulations. Pharmaceutical Research. 41(2). 281–291. 2 indexed citations
4.
Wang, Mengwen, et al.. (2024). Radiation Therapy Improves Survival in Patients with Distant Metastatic Head and Neck Squamous Cell Carcinoma: A Retrospective Study. Journal of Cancer. 16(3). 996–1007. 1 indexed citations
5.
Lin, Xiang, Junyi Jiang, Daojun Hong, et al.. (2023). Biallelic COQ4 Variants in Hereditary Spastic Paraplegia: Clinical and Molecular Characterization. Movement Disorders. 39(1). 152–163. 3 indexed citations
6.
Wang, Mengwen, et al.. (2023). Neurological and imaging phenotypes of adults with untreated phenylketonuria: new cases and literature review. Journal of Neurology. 270(8). 4060–4079. 4 indexed citations
7.
Wang, Mengwen, Yujian Liu, Lei Dai, et al.. (2023). ONX0914 inhibition of immunoproteasome subunit LMP7 ameliorates diabetic cardiomyopathy via restraining endothelial–mesenchymal transition. Clinical Science. 137(16). 1297–1309. 5 indexed citations
9.
Yang, Jianwen, Shengxian Li, Mengwen Wang, et al.. (2023). Y3+ doping and electrochemical properties of LiFe0.5Mn0.5PO4@C cathode material for lithium-ion batteries. Journal of Alloys and Compounds. 960. 170610–170610. 31 indexed citations
10.
Wang, Xuchun, Mingyu Chu, Mengwen Wang, et al.. (2022). Unveiling the Local Structure and Electronic Properties of PdBi Surface Alloy for Selective Hydrogenation of Propyne. ACS Nano. 16(10). 16869–16879. 33 indexed citations
11.
Wang, Mengwen, et al.. (2022). The genetic and phenotypic spectra of adult genetic leukoencephalopathies in a cohort of 309 patients. Brain. 146(6). 2364–2376. 16 indexed citations
12.
Zhong, Xiaodan, Tao Wang, Wenjun Zhang, et al.. (2022). ERK/RSK-mediated phosphorylation of Y-box binding protein-1 aggravates diabetic cardiomyopathy by suppressing its interaction with deubiquitinase OTUB1. Journal of Biological Chemistry. 298(6). 101989–101989. 17 indexed citations
13.
Dai, Lei, Yang Xie, Wenjun Zhang, et al.. (2021). Weighted Gene Co-Expression Network Analysis Identifies ANGPTL4 as a Key Regulator in Diabetic Cardiomyopathy via FAK/SIRT3/ROS Pathway in Cardiomyocyte. Frontiers in Endocrinology. 12. 705154–705154. 23 indexed citations
14.
Dai, Tingting, et al.. (2021). Effects of allyl isothiocyanate on the expression, function, and its mechanism of ABCA1 and ABCG1 in pulmonary of COPD rats. International Immunopharmacology. 101(Pt B). 108373–108373. 10 indexed citations
15.
Wang, Tao, Jinhua Wu, Wei Dong, et al.. (2021). The MEK inhibitor U0126 ameliorates diabetic cardiomyopathy by restricting XBP1's phosphorylation dependent SUMOylation. International Journal of Biological Sciences. 17(12). 2984–2999. 24 indexed citations
16.
Chen, Yijun, Zaiqiang Zhang, Mengwen Wang, et al.. (2021). Novel Compound Missense and Intronic Splicing Mutation in ALDH18A1 Causes Autosomal Recessive Spastic Paraplegia. Frontiers in Neurology. 12. 627531–627531. 4 indexed citations
17.
Wang, Mengwen, et al.. (2020). Novel CAPN1 mutations extend the phenotypic heterogeneity in combined spastic paraplegia and ataxia. Annals of Clinical and Translational Neurology. 7(10). 1862–1869. 10 indexed citations
18.
Fu, Ying, Xiang Lin, Yijun Chen, et al.. (2020). Evolocumab (PCSK9 Inhibitor) in Hereditary Spastic Paraplegia Type 5. SSRN Electronic Journal. 1 indexed citations
19.
Chen, Yijun, Mengwen Wang, En‐Lin Dong, et al.. (2019). Chinese patients with adrenoleukodystrophy and Zellweger spectrum disorder presenting with hereditary spastic paraplegia. Parkinsonism & Related Disorders. 65. 256–260. 10 indexed citations
20.
Zhao, Miao, Yijun Chen, Mengwen Wang, et al.. (2019). Genetic and Clinical Profile of Chinese Patients with Autosomal Dominant Spastic Paraplegia. Molecular Diagnosis & Therapy. 23(6). 781–789. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026